Lankenau Institute for Medical Research(x)
Founded in 1927, the Lankenau Institute for Medical Research is an independent, nonprofit biomedical research center located in suburban Philadelphia on the campus of the Lankenau Hospital. Part of the Main Line Health System, LIMR is one of the few freestanding, hospital associated medical research centers in the nation. Built in 1992, our current facility houses a total of over 85 individuals including 18 principal investigators. Our faculty, under the direction of George C. Prendergast, PhD, is dedicated to advancing an understanding of the causes of cancer and cardiovascular disease in an effort to improve patient diagnosis, develop better treatments, and find new ways to prevent these diseases.
2 Innovations found
| Monoclonal antibody recognizing tissue inhibitor of metalloproteinase-4 (TIMP-4) and its use in a prognostic test to predict clinical outcomes in breast cancer patients. |
|---|
Ductal breast cancers are the most common breast cancers (80%). When tumors are smaller than 20 mm in diameter and without spread of the disease to other sites, patients have traditionally been giv...
| Kits and methods for assessing patient’s susceptibility to cancer or adenoma recurrence, and process for identifying inhibitors of carcinogenesis. |
|---|
The gene ODC encodes for Ornithine decarboxylase, a rate-limiting enzyme in the biosynthesis of polyamines, ubiquitous cellular components that are essential for protein synthesis, mRNA translation...
